Skip to main content

Table 2 Efficacy of select estrogens within CEE to sustain the intracellular ATP level following exposure to β-amyloid25–35 in basal forebrain neurons. Neuronal cultures were pretreated with indicated estrogens for 4 days followed by a 24 hr exposure to 8 μg/ml β-amyloid25–35. The culture medium was replaced and cultures were allowed to incubate for an additional 24 hr followed by determination of the intracellular ATP level. Data are represented as mean ± SEM (n = 7 – 24 from 3 separate experiments). ** P < 0.01 and *** P < 0.001 compared to β-amyloid25–35 alone-treated cultures.

From: Select estrogens within the complex formulation of conjugated equine estrogens (Premarin®) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease

Treatment (pg/ml)

ATP Level (% of β-amyloid25–35 alone group)

Control

203.37 ± 11.67***

β-amyloid25–35 alone

100.00 ± 2.07

17α-estradiol (10)

103.83 ± 3.76

17β-estradiol (10)

131.32 ± 4.56**

Equilin (1000)

114.58 ± 3.56

Equilenin (300)

96.44 ± 4.07

17α-dihydroequilin (1000)

110.00 ± 2.75

17β-dihydroequilin (40)

110.75 ± 2.46

Estrone (5000)

128.84 ± 4.14**

Δ8,9-dehydroestrone (300)

125.05 ± 1.42**